Ms. Hogan, thank you for joining us. It's always a pleasure to see you and your staff.
The COVID‑19 pandemic is an “unforeseen”—I'm using quotation marks—situation, despite 17 years of warnings from scientists.
How should the federal government now determine the level of acceptable risk in contracts for personal protective equipment and medical devices when it doesn't perform financial due diligence?
Should it determine a level of acceptable risk? If so, how should it do so?